Patents by Inventor Bert Clayton

Bert Clayton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC FORMULATIONS AND USES THEREOF
    Publication number: 20240100014
    Abstract: Provided herein are pharmaceutically acceptable compositions containing a selective cyclooxygenase-2 (COX-2) inhibitor (coxib) and optionally buprenorphine. In particular, compositions containing a coxib formulated for oral, topical or subcutaneous administration to treat pain or inflammation are described.
    Type: Application
    Filed: October 23, 2023
    Publication date: March 28, 2024
    Inventors: Douglas Hepler, Gail L. Dempsey, Roland Johnson, Michael Kelly, Michael Daniel, Neil E. Paulsen, Bert Clayton
  • THERAPEUTIC FORMULATIONS AND USES THEREOF
    Publication number: 20230285354
    Abstract: Provided herein are pharmaceutically acceptable compositions containing a selective cyclooxygenase-2 (COX-2) inhibitor (coxib) and optionally buprenorphine. In particular, compositions containing a coxib formulated for oral, topical or subcutaneous administration to treat pain or inflammation are described.
    Type: Application
    Filed: May 12, 2023
    Publication date: September 14, 2023
    Inventors: Douglas I. Hepler, Gail L. Dempsey, Roland Johnson, Michael Kelly, Michael Daniel, Neil Paulsen, Bert Clayton
  • THERAPEUTIC FORMULATIONS AND USES THEREOF
    Publication number: 20210186923
    Abstract: Provided herein are pharmaceutically acceptable compositions containing a selective cyclooxygenase-2 (COX-2) inhibitor (coxib) and optionally buprenorphine. In particular, compositions containing a coxib formulated for oral, topical or subcutaneous administration to treat pain or inflammation are described.
    Type: Application
    Filed: October 29, 2020
    Publication date: June 24, 2021
    Inventors: Douglas I. Hepler, Gail L. Dempsey, Roland Johnson, Michael Kelly, Michael S. Daniel, Neil E. Paulsen, Bert Clayton
  • THERAPEUTIC FORMULATIONS AND USES THEREOF
    Publication number: 20190142789
    Abstract: Provided herein are pharmaceutically acceptable compositions containing a selective cyclooxygenase-2 (COX-2) inhibitor (coxib) and optionally buprenorphine. In particular, compositions containing a coxib formulated for oral, topical or subcutaneous administration to treat pain or inflammation are described.
    Type: Application
    Filed: August 9, 2018
    Publication date: May 16, 2019
    Inventors: Douglas I. Hepler, Gail L. Dempsey, Roland Johnson, Michael Kelly, Michael Daniel, Neil Paulsen, Bert Clayton
  • Lightweight concrete with enhanced neutron shielding
    Patent number: 9440882
    Abstract: A lightweight concrete containing polyethylene terephthalate in an amount of 20% by total volume. The concrete is enriched with hydrogen and is therefore highly effective at thermalizing neutrons. The concrete can be used independently or as a component of an advanced neutron radiation shielding system.
    Type: Grant
    Filed: May 16, 2011
    Date of Patent: September 13, 2016
    Assignee: JEFFERSON SCIENCE ASSOCIATES, LLC
    Inventors: Paul Daniel Brindza, Bert Clayton Metzger
  • Thermal neutron shield and method of manufacture
    Patent number: 8664630
    Abstract: A thermal neutron shield comprising boron shielding panels with a high percentage of the element Boron. The panel is least 46% Boron by weight which maximizes the effectiveness of the shielding against thermal neutrons. The accompanying method discloses the manufacture of boron shielding panels which includes enriching the pre-cursor mixture with varying grit sizes of Boron Carbide.
    Type: Grant
    Filed: May 16, 2011
    Date of Patent: March 4, 2014
    Assignee: Jefferson Science Associates, LLC
    Inventors: Bert Clayton Metzger, Paul Daniel Brindza
  • Thermal neutron shield and method of manufacture
    Patent number: 8450707
    Abstract: A thermal neutron shield comprising concrete with a high percentage of the element Boron. The concrete is least 54% Boron by weight which maximizes the effectiveness of the shielding against thermal neutrons. The accompanying method discloses the manufacture of Boron loaded concrete which includes enriching the concrete mixture with varying grit sizes of Boron Carbide.
    Type: Grant
    Filed: March 22, 2011
    Date of Patent: May 28, 2013
    Assignee: Jefferson Science Associates, LLC
    Inventors: Paul Daniel Brindza, Bert Clayton Metzger